Spruce Biosciences, Inc. (SPRB)

Spruce Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.62	38.75	96.34	24.49	42.75	157.15
Short-Term Investments	-	-	-	54.59	46.22	-
Cash & Short-Term Investments	25.62	38.75	96.34	79.08	88.97	157.15
Cash Growth	-68.44%	-59.77%	21.83%	-11.12%	-43.39%	3904.84%
Prepaid Expenses	2.9	3.18	3.88	3.32	2.53	2.97
Restricted Cash	-	-	-	0.22	-	-
Other Current Assets	2.06	2.28	1.97	1	0.4	0.28
Total Current Assets	30.58	44.21	102.18	83.61	91.9	160.4
Property, Plant & Equipment	0.87	0.93	1.18	1.4	1.48	1.87
Long-Term Investments	-	-	-	-	32.46	-
Other Long-Term Assets	0.2	0.07	0.58	0.64	0.65	0.62
Total Assets	31.65	45.21	103.95	85.65	126.49	162.88
Accounts Payable	1.88	1.3	3.33	1.43	2.82	3.63
Accrued Expenses	11.56	12.05	14.35	9.26	5.69	3.33
Current Portion of Long-Term Debt	1.35	1.62	1.62	1.62	-	2.55
Current Portion of Leases	0.29	0.28	0.25	0.14	0.36	0.25
Current Unearned Revenue	-	-	4.91	-	-	-
Total Current Liabilities	15.67	15.25	24.47	12.45	8.87	9.76
Long-Term Debt	-	0.12	1.72	3.29	4.88	1.92
Long-Term Leases	0.66	0.74	1.02	1.26	1.29	1.65
Other Long-Term Liabilities	-	0.28	0.24	0.16	0.07	0.12
Total Liabilities	16.33	16.39	27.44	17.16	15.12	13.46
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	279.63	279.09	273.74	218.35	214.69	210.27
Retained Earnings	-264.31	-250.27	-197.23	-149.31	-103.13	-60.84
Comprehensive Income & Other	-	-	-	-0.56	-0.18	-
Total Common Equity	15.32	28.82	76.51	68.49	111.37	149.43
Shareholders' Equity	15.32	28.82	76.51	68.49	111.37	149.43
Total Liabilities & Equity	31.65	45.21	103.95	85.65	126.49	162.88
Total Debt	2.3	2.77	4.61	6.32	6.53	6.38
Net Cash (Debt)	23.32	35.99	91.73	72.76	82.44	150.77
Net Cash Growth	-69.72%	-60.77%	26.07%	-11.74%	-45.32%	-
Net Cash Per Share	0.56	0.87	2.38	3.09	3.53	25.17
Filing Date Shares Outstanding	42.23	42.23	41.15	39.75	23.49	23.3
Total Common Shares Outstanding	42.23	42.23	41.03	23.6	23.49	23.26
Working Capital	14.91	28.96	77.72	71.16	83.02	150.63
Book Value Per Share	0.36	0.68	1.86	2.90	4.74	6.42
Tangible Book Value	15.32	28.82	76.51	68.49	111.37	149.43
Tangible Book Value Per Share	0.36	0.68	1.86	2.90	4.74	6.42
Machinery	-	-	-	-	-	0.06
Leasehold Improvements	-	-	-	-	-	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.